3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Status
Unknown
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Gastrointestinal
1
CNS
1
Conditions
Rectal Neoplasms
1
Glioma
1
Glioblastoma
1
Cystitis, Hemorrhagic
1
Interventions
Cisplatin
1519
Carboplatin
1420
Cyclophosphamide
1360
Gemcitabine
1235
Bevacizumab
1226
Paclitaxel
1211
Radiotherapy
1176
Docetaxel
1080
pembrolizumab
1028
Oxaliplatin
936
Capecitabine
900
Fluorouracil
833
Rituximab
729
Doxorubicin
683
Nivolumab
679
Dexamethasone
666
Etoposide
660
Irinotecan
622
Leucovorin
575
Pemetrexed
510
Drug Therapy
493
Cetuximab
483
Trastuzumab
469
Cytarabine
466
Magnetic Resonance Spectroscopy
458
Filgrastim
446
Prednisone
432
Lenalidomide
409
Specimen Handling
408
Temozolomide
400
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 2
×
Interventional
×
chlorophyllin
×
Clear all
NCT05856305
2025-09-26
SCOTCH
Tata Memorial Centre
Phase 2
Active not recruiting
76 enrolled
NCT06016452
2025-04-11
CHROME
Tata Memorial Centre
Phase 2
Recruiting
118 enrolled
NCT05348239
2022-04-27
CLARITY
Tata Memorial Centre
Phase 2
Unknown
24 enrolled